Aditya Kumar Bubna

Therapeutics in Dermatology - Essentials for Clinical Practice

Systemic Therapy: Volume 2

• Gebundenes Buch

Produktbeschreibung

This comprehensive volume offers a one-stop reference for everything related to dermatologic therapeutics covering both foundational knowledge and the latest advancements in the field. Designed for clarity and depth, the book offers a concise, yet thorough explanations of each drug, including, mechanism of action, pharmacokinetics, indications and contraindications, clinical applications adverse effects. Besides, the utility of these drugs in pregnancy, lactation, pediatric, and geriatric populations has also been highlighted .

Whether you're exploring systemic or topical therapies, this book provides a detailed roadmap. It delves into non-biologic immunomodulators, anti-androgens, attenuated androgens, anti-parasitic agents, vitamins and minerals, and drugs used in psychodermatology. Further, in the section on miscellaneous drugs, drugs like rivaroxaban, bosentan, sildenafil, naltrexone, oral anticholinergic drugs and metformin have been very comprehensively discussed, which often are missed in most dermatology textbooks. Additionally, for newer drugs, the presentation takes into consideration all recent relevant data, including the rationale regarding the utility of that drug for the concerned indication.

Enhanced with clear flow diagrams and structured insights, this book is an indispensable resource for dermatologists, medical students, and healthcare professionals seeking a deeper understanding of therapeutic strategies in dermatology. This is volume 2 of the set of three volumes.

Produktdetails

• Verlag: Springer, Berlin; Springer
• Artikelnr. des Verlages: 978-981-95-3794-5
• Seitenzahl: 589
• Erscheinungstermin: 2. Januar 2026
• Englisch
• Abmessung: 235mm x 155mm
• ISBN-13: 9789819537945
• ISBN-10: 9819537940
• Artikelnr.: 75457242

Autorenporträt

Dr. Aditya Kumar Bubna is a Dermatologist, currently working as an Associate Professor in the Department of Dermatology, Katihar Medical College, Katihar, India. He has more than 50 publications in national and international journals. His particular interest is dermatologic therapeutics, with a keen interest on various pharmacologic and therapeutic aspects of dermatologic drugs, both topical and systemic. He feels that a thorough knowledge in this regard assists in the introduction of innovative strategies, that can significantly aid in reducing the frequency of conventional drug administration, thereby helping in alleviating the prevalence of side effects. He further percieves that safety and efficacy of drugs go hand in hand when it comes to treating patients, and a thorough knowledge of these drugs therefore becomes essential for all clinicians. His other interest in this field includes dermatopathology, an indispensable facet of diagnostic dermatology.

Inhaltsangabe

Section VIII  Non biologic immunomodulators.
Chapter 42  Apremilast.
Chapter 43  Janus kinase inhibitors.
Chapter 44  Tyrosine kinase inhibitors.
Section IX  Antiandrogens.
Chapter 45  Spironolactone.
Chapter 46  Finasteride.
Chapter 47  Dutasteride.
Chapter 48  Flutamide.
Chapter 49  Bicalutamide.
Chapter 50  Cyproterone acetate.
Section X  Attenuated androgens.
Chapter 51  Danazol.
Chapter 52  Stanozolol.
Section XI  Miscellaneous drugs.
Chapter 53  Antimalarials.
Chapter 54  Thalidomide.
Chapter 55  Aspirin.
Chapter 56  Levamisole.
Chapter 57  Clofazimine.
Chapter 58  Dapsone.
Chapter 59  Fumaric acid esters.
Chapter 60  Leflunomide.
Chapter 61  Niacinamide.
Chapter 62  Colchicine.
Chapter 63  Pentoxifylline.
Chapter 64  Leukotriene antagonists.
Chapter 65  Psoralens.
Chapter 66  Vorinostat.
Chapter 67  Potassium iodide.
Chapter 68  Antihypertensives in dermatology.
Chapter 69  Vismodegib.
Chapter 70  IVIG.
Chapter 71  Antihistamines.
Chapter 72  Rivaroxaban.
Chapter 73  Bosentan.
Chapter 74  Sildenafil.
Chapter 75  Naltrexone.
Chapter 76  Anticholinergic drugs.
Chapter 77  Tranexemic acid.
Chapter 78  Metformin.
Section XII  Antiparasite drugs.
Chapter 79  Miltefosine.
Chapter 80  Ivermectin.
Chapter 81  Albendazole.
Chapter 82  DEC.
Chapter 83  Praziquantel.
Section XIII  Vitamins and minerals.
Chapter 84  Vitamin D.
Chapter 85  Vitamin C.
Chapter 86  Vitamin E.
Chapter 87  Zinc.
Section XIV  Psychodermatology drugs.
Chapter 88  Drugs used in psychodermatology.